Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 216-904-5 | CAS number: 1694-31-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- data is from Authoritative database
Data source
Referenceopen allclose all
- Reference Type:
- other: Authoritative database
- Title:
- Acute oral toxicity study of test chemical was performed in rodents.
- Author:
- U.S. National Library of Medicine
- Year:
- 2 018
- Bibliographic source:
- Chemidplus Database,U.S. National Library of Medicine,2018
- Reference Type:
- secondary source
- Title:
- Acute oral toxicity study of test chemical was performed in rodents.
- Author:
- NTRL
- Year:
- 1 997
- Bibliographic source:
- NTRL REPORT,1997
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EPA OTS 798.1175 (Acute Oral Toxicity)
- Principles of method if other than guideline:
- Acute oral toxicity study of test chemical was performed in rodents.
- GLP compliance:
- not specified
- Test type:
- other: not specified
- Limit test:
- no
Test material
- Reference substance name:
- tert-butyl acetate
- Cas Number:
- 540-88-6
- Molecular formula:
- C6H12O2
- IUPAC Name:
- tert-butyl acetate
- Details on test material:
- - Name of test material (IUPAC name): tert-butyl acetate- Common name: 1,1-Dimethyl acetate- Molecular formula: C6H12O2- Molecular weight: 116.1588 g/mol- Smiles notation: C(OC(C)=O)(C)(C)C- InChl: 1S/C6H12O2/c1-5(7)8-6(2,3)4/h1-4H3- Substance type: Organic
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Details on test animalTEST ANIMALS- Source: Ace Animals, Boyertown, PA- Age at study initiation: healthy male and healthy, non-pregnant and nulliparous female Wistar albino rats were taken. The animals were bom the weeks of 4/22 through 5/27/97.- Weight at study initiation: 265-296 grams : males 201-280 grams : females- Diet (e.g. ad libitum): Fresh Purina Rat Chow (Diet #5012) was freely available except for 16-20 hours prior to dosing- Water (e.g. ad libitum): Water was freely available at all times.- Acclimation period: a quarantine period of at least one weekENVIRONMENTAL CONDITIONS- Photoperiod (hrs dark / hrs light): 12 hour light/dark cycleIN-LIFE DATES: From: 07/18/97 To: 08/01/97
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- not specified
- Details on oral exposure:
- no data
- Doses:
- 2000,5000,7000 mg/kg bw
- No. of animals per sex per dose:
- Total:30 rats2000 mg/kg bw: 5 male and 5 female5000 mg/kg bw: 5 male and 5 female7000 mg/kg bw: 5 male and 5 female
- Control animals:
- not specified
- Details on study design:
- Details on study design:- Duration of observation period following administration: 14 days- Frequency of observations and weighing: In Vivo - Animals were observed 1, 2 and 4 hours postdose and once daily for 14 days for toxicity and pharmacological effects. The animals were observed twice daily for mortality. Body weights were recorded immediately pretest, weekly, at death and at termination in the survivors.Post Mortem - All animals were examined for gross pathology. Abnormal tissues were preserved in 10%buffered formalin for possible future microscopic examination.- Necropsy of survivors performed: yes- Other examinations performed: clinical signs, body weight,organ weights, histopathology
- Statistics:
- The LD50 and 95% Confidence Limits were calculated by the method of Litchfield J.T. Jr., &F. Wilcoxon JPET96:99.
Results and discussion
- Preliminary study:
- Five healthy male and five healthy female Wistar albino rats were dosed orally with tert-butyl acetate at 5000 mg/kg of body weight. Since mortality occurred at this level, additional groups were dosed at 2000,5000 and 7000 mg/kg bw.
Effect levelsopen allclose all
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 4 100 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 3 185 - 5 277
- Remarks on result:
- other: 50% mortality was observed
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 4 750 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 3 848 - 5 864
- Remarks on result:
- other: 50% mortality was observed
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 4 500 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 3 783 - 5 353
- Remarks on result:
- other: 50% mortality was observed
- Mortality:
- 50% mortality was observed
- Clinical signs:
- other: Predeath physical signs included ataxia, flaccid muscle tone, lethargy, dyspnea, loss of righting reflex, prostration, piloerection, tremors and coma. Physical signs in the surviving animals of the 2000 and 5000 mg/kg groups included ataxia, flaccid muscl
- Gross pathology:
- Necropsy findings in the animals which died during the study included abnormalities of the lungs, spleen, kidneys, liver, stomach, intestines, as well as wetness and red & brown staining of the nose/mouth area. Necropsy findings in the animals which survived the study were normal.
- Other findings:
- no data
Any other information on results incl. tables
Table:Mortality response to the three oral dose levels was:
Dose mg/kg | # Treated M/F | # Dead M/F |
2000 | 5/5 | 0/0 |
5000 | 5/5 | 4/2 |
7000 | 5/5 | 5/5 |
Table: TOXICITY CODE
B = Lethargy
C = Flaccid
E = Ataxia
F = Piloerection
G = Prostrate
H = coma
K = Negative righting reflex
M = Dyspnea
0 = Tremors
S = Chromorhinorrhea
V = Bloated abdomen
Z = Dead
Table : Systemic Observations
Dose level: 2000 mg/kg bw
TIME PERIODS | ANIMAL # / SEX | |||||||||
11-M | 12-M | 13-M | 14-M | 15-M | 16-F | 17-F | 18-F | 19-F | 20-F | |
Hours 1 |
| B,E | B,E |
|
| B | B | B | B | B,E |
Hours 2 | B,E |
|
|
| B | B,E | B,E | B,E |
|
|
Hours 4 |
|
|
|
|
| B | B,E | B |
|
|
Day 1 |
|
|
|
| S |
|
|
|
|
|
Day 2 |
|
|
|
|
|
|
|
|
|
|
Day 3 |
|
|
|
|
|
|
|
|
|
|
Day 4 |
|
|
|
|
|
|
|
|
|
|
Day 5 |
|
|
|
|
|
|
|
|
|
|
Day 6 |
|
|
|
|
|
|
|
|
|
|
Day 7 |
|
|
|
|
|
|
|
|
|
|
Day 8 |
|
|
|
|
|
|
|
|
|
|
Day 9 |
|
|
|
|
|
|
|
|
|
|
Day 10 |
|
|
|
|
|
|
|
|
|
|
Day 11 |
|
|
|
|
|
|
|
|
|
|
Day 12 |
|
|
|
|
|
|
|
|
|
|
Day 13 |
|
|
|
|
|
|
|
|
|
|
Day 14 |
|
|
|
|
|
|
|
|
|
|
Day 15 |
|
|
|
|
|
|
|
|
|
|
No entry Indicates animal appeared normal at that observation period. Systemic observation code is on page preceding systemic observation tables.
Table: Systemic Observations (continued)
Dose level: 5000 mg/kg bw
TIME PERIODS | ANIMAL # / SEX | |||||||||
1-M | 2-M | 3-M | 4-M | 5-M | 6-F | 7-F | 8-F | 9-F | 10-F | |
Hours 1 | B,E | B,E | B,E,G | B,E | B,E | B,E,G | B,E | B,E,C | B,E | B,E,G |
Hours 2 | B,E,G | B,E,G | B,E,G | B,E,G | B,E,G | B,E,G | B,E | B,E,C,G | B,E,G | B,E,G |
Hours 4 | B | B,E | B | B,E,Z (213 g) | B | B | Z | B,E,C,G | B,E,G |
|
Day 1 | Z(272 g) | V | Z(307 g) |
| Z(275 g) | B,E |
| Z(215 g) | C,F |
|
Day 2 |
|
|
|
|
|
|
|
|
|
|
Day 3 |
|
|
|
|
|
|
|
|
|
|
Day 4 |
|
|
|
|
|
|
|
|
|
|
Day 5 |
|
|
|
|
|
|
|
|
|
|
Day 6 |
|
|
|
|
|
|
|
|
|
|
Day 7 |
|
|
|
|
|
|
|
|
|
|
Day 8 |
|
|
|
|
|
|
|
|
|
|
Day 9 |
|
|
|
|
|
|
|
|
|
|
Day 10 |
|
|
|
|
|
|
|
|
|
|
Day 11 |
|
|
|
|
|
|
|
|
|
|
Day 12 |
|
|
|
|
|
|
|
|
|
|
Day 13 |
|
|
|
|
|
|
|
|
|
|
Day 14 |
|
|
|
|
|
|
|
|
|
|
Day 15 |
|
|
|
|
|
|
|
|
|
|
No entry Indicates animal appeared normal at that observation period. Systemic observation code Is on page preceding systemic observation tables.
Table 2: Systemic Observations (continued)
Dose level:7000 mg/kg bw
TIME PERIODS | ANIMAL # / SEX | |||||||||
21-M | 22-M | 23-M | 24-M | 25-M | 26-F | 27-F | 28-F | 29-F | 30-F | |
Hours 1 | C,G,M | C,E | B,E | Z | B,E | Z | C,G | C,G | C,M,G | C,G |
Hours 2 | Z | C,G,K | B,E |
| B,E,O |
| Z | C,G | Z | Z |
Hours 4 |
| C,E,F | Z |
| H,M |
|
| Z |
|
|
Day 1 |
| Z(258 g) |
|
| Z(269 g) |
|
|
|
|
|
Day 2 |
|
|
|
|
|
|
|
|
|
|
Day 3 |
|
|
|
|
|
|
|
|
|
|
Day 4 |
|
|
|
|
|
|
|
|
|
|
Day 5 |
|
|
|
|
|
|
|
|
|
|
Day 6 |
|
|
|
|
|
|
|
|
|
|
Day 7 |
|
|
|
|
|
|
|
|
|
|
Day 8 |
|
|
|
|
|
|
|
|
|
|
Day 9 |
|
|
|
|
|
|
|
|
|
|
Day 10 |
|
|
|
|
|
|
|
|
|
|
Day 11 |
|
|
|
|
|
|
|
|
|
|
Day 12 |
|
|
|
|
|
|
|
|
|
|
Day 13 |
|
|
|
|
|
|
|
|
|
|
Day 14 |
|
|
|
|
|
|
|
|
|
|
Day 15 |
|
|
|
|
|
|
|
|
|
|
Table: Necropsy Observations
Dose level: 2000 mg/kg bw
OBSERVATION Death/Sacrifice | 11 M S | 12 M S | 13 M S | 14 M S | 15 M S | 16 F S | 17 F S | 18 F S | 19 F S | 20 F S |
Normal | X | X | X | X | X | X | X | X | X | X |
CODES: S = sacrifice
X= observed
Table 3: Necropsy Observations (continued)
Dose Level: 5000 mg/kg
OBSERVATION Death/Sacrifice | 1 M D | 2 M S | 3 M D | 4 M D | 5 M D | 6 F S | 7 F D | 8 F D | 9 F S | 10 F S |
Normal |
| X |
|
|
| X |
|
| X | X |
Nose/mouth - stained red |
|
|
|
|
|
| 1 |
|
|
|
Nose/mouth - stained brown |
|
|
|
| 1 |
|
|
|
|
|
Nose/mouth - wet |
|
|
|
|
|
| 1 |
|
|
|
Lungs - darker than normal | 2 |
| 2 | 2 | 2 |
| 2 | 2 |
|
|
Lungs - red areas | 2 |
| 1 | 2 | 2 |
| 2 | 2 |
|
|
Liver - pale areas |
|
| 2 |
| 2 |
|
| 1 |
|
|
Liver - darker than normal | 1 |
| 1 | 2 |
|
| 2 | 1 |
|
|
Kidney - pale areas on left one | 1 |
| 2 |
| 1 |
|
| 1 |
|
|
Stomach - red |
|
|
|
| 2 |
|
|
|
|
|
Stomach· distended with gas |
|
| 3 |
|
|
|
|
|
|
|
Stomach - pale | 2 |
|
|
|
|
|
| 2 |
|
|
Intestines - red areas | 1 |
| 1 | 1 | 2 |
|
| 2 |
|
|
Intestines - distended with mucus |
|
| 2 |
| 1 |
|
| 1 |
|
|
Intestines - pale | 2 |
| 1 | 1 | 1 |
| 3 | 2 |
|
|
Spleen - pale |
|
| 2 |
|
|
|
| 1 |
|
|
CODES: D=death
S = sacrifice
X= observed
1=slight or scattered
2= moderate or few
3= pronounced or many
Table 3: Necropsy Observations (continued)
Dose Level: 7000 mg/kg
OBSERVATION Death/Sacrifice | 21 M D | 22 M D | 23 M D | 24 M D | 25 M D | 26 F D | 27 F D | 28 F D | 29 F D | 30 F D |
Nose/mouth - wet |
|
|
| 1 |
| 1 | 1 | 1 |
| 1 |
Lungs - darker than normal | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 |
Lungs - red areas | 1 | 3 | 1 | 2 | 3 | 1 |
| 2 | 2 | 1 |
Liver - darker than normal | 1 |
| 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Stomach - red | 1 |
| 2 | 2 |
| 1 | 1 |
| 2 | 1 |
Stomach· distended with gas | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
Stomach –lining pale |
|
|
|
| 2 |
|
| 2 |
|
|
Intestines - red areas | 1 | 2 |
| 1 | 2 | 1 | 1 | 1 |
|
|
Intestines - distended with mucus | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 2 |
Intestines - pale |
|
| 2 |
| 2 | 1 |
| 2 | 1 | 2 |
CODES: D = death
1= slight or scattered
2= moderate or low
3= pronounced or many
Applicant's summary and conclusion
- Interpretation of results:
- other: not classified
- Conclusions:
- The lethal concentration (LD50) value for acute oral toxicity test was considered to be 4100 mg/kg bw in males;4750 mg/kg bw in females and 4500 mg/kg bw in both sex,when male and female wistar albino rats were treated with test chemical orally via gavage according to Health Effects Testing Guidelines, 40 CFR Part 798.1175.
- Executive summary:
Acute oral toxicity study was performed in male and female wistar albino rats using test chemical via gavage according to Health Effects Testing Guidelines, 40 CFR Part 798.1175.50% mortality was observed at dose 4100 mg/kg bw in males,4750 mg/kg bw in females and 4500 mg/kg bw for both sex.Predeath physical signs included ataxia, flaccid muscle tone, lethargy, dyspnea, loss of righting reflex, prostration, piloerection, tremors and coma. Physical signs in the surviving animals of the 2000 and 5000 mg/kg groups included ataxia, flaccid muscle tone, lethargy, bloated abdomen, piloerection, chromorhinorrhea and assumption of a prostrate position. Body weight changes in the surviving animals in the 2000 and 5000 mg/kg groups were normal. Necropsy findings in the animals which died during the study included abnormalities of the lungs, spleen, kidneys, liver, stomach, intestines, as well as wetness and red & brown staining of the nose/mouth area. Necropsy findings in the animals which survived the study were normal.Hence,LD50 value was considered to be 4100;4750 and 4500 mg/kg bw,when rats were treated with test chemical orally via gavage.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.